Publikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Tarragona Joan XXIII (38)

2023

  1. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

2022

  1. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  2. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

    Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89

2021

  1. Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain

    Critical Care, Vol. 25, Núm. 1

  2. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia

    ERJ Open Research, Vol. 7, Núm. 1

  3. Limiting ICU admission from emergency services and wards

    Medicina Clinica, Vol. 157, Núm. 11, pp. 524-529

2020

  1. Associated risk factors and outcomes of acute kidney injury in severe trauma: Results from the Spanish trauma ICU registry (RETRAUCI)

    Anaesthesia Critical Care and Pain Medicine, Vol. 39, Núm. 4, pp. 503-506

  2. Oversedation Zero as a tool for comfort, safety and intensive care unit management

    Medicina Intensiva, Vol. 44, Núm. 4, pp. 239-247

  3. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)

    Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388

2019

  1. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients with Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial

    JAMA

2017

  1. Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case–control study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 1, pp. 123-130

2016

  1. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions

    Critical Care, Vol. 20, Núm. 1

  2. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  3. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

    Journal of Infection, Vol. 72, Núm. 2, pp. 143-151

2015

  1. Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy

    Intensive Care Medicine Experimental

  2. Pneumococcal pneumonia coinfection in critically ill patients with influenza a (H1n1) primary viral pneumonia

    Intensive Care Medicine Experimental

2013

  1. Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy

    Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326

  2. Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia

    Intensive Care Medicine, Vol. 39, Núm. 4, pp. 693-702

2012

  1. Corticosteroid therapy in patients with primary viralpneumonia due to pandemic (H1N1) 2009influenza

    Journal of Infection, Vol. 64, Núm. 3, pp. 311-318

  2. Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente Crítico (GEIPC) de la Sociedad Espanola de Enfermedades Infecciosas y Microbiología clinica (SEIMC) para el diagnóstico y tratamiento de la gripe A/H1N1

    Medicina Intensiva, Vol. 36, Núm. 2, pp. 103-137